Following priority review, the U.S. Food and Drug Administration approved Bayer's Kerendia (finerenone) for the treatment of ...

In a significant move, the U.S. Food and Drug Administration granted approval for Kerendia for patients with heart failure ...

New research explains how low levels of the electrolyte sodium in the blood can disrupt the timing of the heartbeat in ...

New research explains how low levels of the electrolyte sodium in the blood can disrupt the timing of the heartbeat in patients taking widely used rhythm-control medications such as flecainide, which ...